journal article·2022-12

Selective targeting of visceral adiposity by polycation nanomedicine

Qianfen Wan, Baoding Huang, Tianyu Li, Yang Xiao, Ying He, Wen Du, Branden Z. Wang, Gregory F. Dakin, Michael Rosenbaum, Marcus D. Goncalves, Shuibing Chen, Kam W. Leong, Li Qiang

Nature Nanotechnology· Volume 17· Issue 12
Publisher page

Abstract

Obesity is a pandemic health problem with poor solutions, especially for targeted treatment. Here we develop a polycation-based nanomedicine polyamidoamine generation 3 (P-G3) that-when delivered intraperitoneally-selectively targets visceral fat due to its high charge density. Moreover, P-G3 treatment of obese mice inhibits visceral adiposity, increases energy expenditure, prevents obesity and alleviates the associated metabolic dysfunctions. In vitro adipogenesis models and single-cell RNA sequencing revealed that P-G3 uncouples adipocyte lipid synthesis and storage from adipocyte development to create adipocytes that possess normal functions but are deficient in hypertrophic growth, at least through synergistically modulating nutrient-sensing signalling pathways. The visceral fat distribution of P-G3 is enhanced by modifying P-G3 with cholesterol to form lipophilic nanoparticles, which is effective in treating obesity. Our study highlights a strategy to target visceral adiposity and suggests that cationic nanomaterials could be exploited for treating metabolic diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Adipose Tissue and Metabolism · Immune cells in cancer · Adipokines, Inflammation, and Metabolic Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Danaei, G. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6, e1000058 (2009).10.1371/journal.pmed.1000058 ↗
2. Verboven, K. et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci. Rep. 8, 4677 (2018).10.1038/s41598-018-22962-x ↗
3. Kajimura, S., Spiegelman, B. M. & Seale, P. Brown and beige fat: physiological roles beyond heat generation. Cell Metab. 22, 546–559 (2015).10.1016/j.cmet.2015.09.007 ↗
4. Huffman, D. M. & Barzilai, N. Role of visceral adipose tissue in aging. Biochim. Biophys. Acta 1790, 1117–1123 (2009).10.1016/j.bbagen.2009.01.008 ↗
5. Svenson, S. & Tomalia, D. A. Dendrimers in biomedical applications—reflections on the field. Adv. Drug Deliv. Rev. 57, 2106–2129 (2005).10.1016/j.addr.2005.09.018 ↗
6. Lee, J. et al. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl Acad. Sci. USA 108, 14055–14060 (2011).10.1073/pnas.1105777108 ↗
7. Lee, J. et al. Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials 120, 94–102 (2017).10.1016/j.biomaterials.2016.12.024 ↗
8. Pisetsky, D. S., Lee, J., Leong, K. W. & Sullenger, B. A. Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack. Expert Rev. Clin. Immunol. 8, 1–3 (2012).10.1586/eci.11.82 ↗
9. Mariman, E. C. & Wang, P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell. Mol. Life Sci. 67, 1277–1292 (2010).10.1007/s00018-010-0263-4 ↗
10. Puri, S., Coulson-Thomas, Y. M., Gesteira, T. F. & Coulson-Thomas, V. J. Distribution and function of glycosaminoglycans and proteoglycans in the development, homeostasis and pathology of the ocular surface. Front Cell Dev. Biol. 8, 731 (2020).10.3389/fcell.2020.00731 ↗
11. Esfand, R. & Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Disco. Today 6, 427–436 (2001).10.1016/S1359-6446(01)01757-3 ↗
12. Pajvani, U. B. et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 11, 797–803 (2005).10.1038/nm1262 ↗
13. Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C. & Lazar, M. A. Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. Proc. Natl Acad. Sci. USA 110, 18656–18661 (2013).10.1073/pnas.1314863110 ↗
14. Farmer, S. R. Transcriptional control of adipocyte formation. Cell Metab. 4, 263–273 (2006).10.1016/j.cmet.2006.07.001 ↗
15. Li, D. et al. Distinct functions of PPARγ isoforms in regulating adipocyte plasticity. Biochem. Biophys. Res. Commun. 481, 132–138 (2016).10.1016/j.bbrc.2016.10.152 ↗
16. La Manno, G. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).10.1038/s41586-018-0414-6 ↗
17. Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).10.1038/s41587-020-0591-3 ↗
18. Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).10.1038/nmeth.4463 ↗
19. Hwang, M. E., Keswani, R. K. & Pack, D. W. Dependence of PEI and PAMAM gene delivery on clathrin- and caveolin-dependent trafficking pathways. Pharm. Res. 32, 2051–2059 (2015).10.1007/s11095-014-1598-6 ↗
20. Fox, L. J., Richardson, R. M. & Briscoe, W. H. PAMAM dendrimer-cell membrane interactions. Adv. Colloid Interface Sci. 257, 1–18 (2018).10.1016/j.cis.2018.06.005 ↗
21. Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W. & Ghandehari, H. Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm. Res. 24, 2138–2145 (2007).10.1007/s11095-007-9415-0 ↗
22. Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).10.1016/j.cell.2017.02.004 ↗
23. Chung, C. Y. et al. Covalent targeting of the vacuolar H(+)-ATPase activates autophagy via mTORC1 inhibition. Nat. Chem. Biol. 15, 776–785 (2019).10.1038/s41589-019-0308-4 ↗
24. Rajman, L., Chwalek, K. & Sinclair, D. A. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 27, 529–547 (2018).10.1016/j.cmet.2018.02.011 ↗
25. Ryu, K. W. et al. Metabolic regulation of transcription through compartmentalized NAD(+) biosynthesis. Science 360, eaan5780 (2018).10.1126/science.aan5780 ↗
26. Zhang, Y. et al. Locally induced adipose tissue browning by microneedle patch for obesity treatment. ACS Nano 11, 9223–9230 (2017).10.1021/acsnano.7b04348 ↗
27. Andrew, M. S. et al. Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons. Surg. Obes. Relat. Dis. 14, 833–841 (2018).10.1016/j.soard.2018.03.004 ↗
28. Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242–258 (2019).10.1038/s41580-018-0093-z ↗
29. Tandon, P., Wafer, R. & Minchin, J. E. N. Adipose morphology and metabolic disease. J. Exp. Biol. 221, jeb164970 (2018).10.1242/jeb.164970 ↗
30. Acosta, J. R. et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 59, 560–570 (2016).10.1007/s00125-015-3810-6 ↗
31. Brown, J. M. et al. Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J. Biol. Chem. 279, 26735–26747 (2004).10.1074/jbc.M401766200 ↗
32. House, R. L. et al. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol. Genomics 21, 351–361 (2005).10.1152/physiolgenomics.00244.2004 ↗
33. Van, R. L., Bayliss, C. E. & Roncari, D. A. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J. Clin. Invest. 58, 699–704 (1976).10.1172/JCI108516 ↗
34. Negrel, R., Grimaldi, P. & Ailhaud, G. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc. Natl Acad. Sci. USA 75, 6054–6058 (1978).10.1073/pnas.75.12.6054 ↗
35. Verges, B., Walter, T. & Cariou, B. Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism. Eur. J. Endocrinol. 170, R43–R55 (2014).10.1530/EJE-13-0586 ↗
36. Zhang, Y. & Chua, S. Jr. Leptin function and regulation. Compr. Physiol. 8, 351–369 (2017).10.1002/cphy.c160041 ↗
37. Leong, K. W., & Qiang, L. Targeting obesity: eliminating visceral fat. Columbia Engineering Magazine (spring 2022).
38. Higuchi, S. et al. Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice. Gut 69, 1620–1628 (2020).10.1136/gutjnl-2019-319693 ↗
39. Brown, B. N. et al. Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix. Tissue Eng. Part C Methods 17, 411–421 (2011).10.1089/ten.tec.2010.0342 ↗
40. Lee, M. J. & Fried, S. K. Optimal protocol for the differentiation and metabolic analysis of human adipose stromal cells. Methods Enzymol. 538, 49–65 (2014).10.1016/B978-0-12-800280-3.00004-9 ↗
41. Lee, M. J., Gong, D. W., Burkey, B. F. & Fried, S. K. Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am. J. Physiol. Endocrinol. Metab. 300, E571–E580 (2011).10.1152/ajpendo.00231.2010 ↗